Spyre Therapeutics prices $403M public stock offering at $62
Entity Intersection Graph
No entity connections available yet for this article.
More from USA
- Utah DA declines to file charges against Taylor Frankie Paul over domestic violence allegations
- Bank of Korea Governor nominee Shin signals hawkish policy if inflation persists
- US agencies test Anthropic’s advanced AI model despite Trump ban - Politico
- Iran used Chinese spy satellite to target US bases, FT reports
- Factbox-Oil tankers transiting Strait of Hormuz since start of Iran war
- Nebraska suspect killed after alleged kidnap attempt
News from Other Countries
🇬🇧 United Kingdom
- Harry says children should be an 'upgrade' of their parents
- Margo’s Got Money Troubles review – Michelle Pfeiffer’s career renaissance starts here
- Gina Rinehart’s Hancock Prospecting to pay hundreds of millions’ worth of royalties to rival family in ‘half loss half win’